Parenteral nutrition-associated hepatotoxicity

Nutrition in Clinical Practice

Volumn 19, Issue 3, 2004, Pages 274-283

  Fulford, Andrea ^a   Scolapio, James S ^a   Aranda Michel, Jaime ^a,b  

^a MAYO CLINIC   (United States)

^b Hepatology and Liver Transplant   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; CARNITINE; CHOLECYSTOKININ; CHOLINE; ESSENTIAL AMINO ACID; GLUTAMINE; TAURINE; URSODEOXYCHOLIC ACID;

AMINO ACID DEFICIENCY; BILIARY SLUDGE; CHOLESTASIS; CLINICAL TRIAL; DIAGNOSTIC TEST; DISEASE ASSOCIATION; HEPATOBILIARY DISEASE; HUMAN; LABORATORY TEST; LIVER CIRRHOSIS; LIVER TOXICITY; LIVER TRANSPLANTATION; MACRONUTRIENT; MEDICAL LITERATURE; META ANALYSIS; NUTRITIONAL DEFICIENCY; OVERNUTRITION; PARENTERAL NUTRITION; PATHOGENESIS; REVIEW; RISK FACTOR; STEATOSIS; SYSTEMATIC REVIEW; VITAMIN DEFICIENCY;

EID: 2942537753     PISSN: 08845336     EISSN: None     Source Type: Journal    
DOI: 10.1177/0115426504019003274     Document Type: Review

References (113)

1. Angelico M, Della Guardia P. Review article: Hepatobiliary complications associated with TPN. Aliment Pharmacol Ther. 2000;14:54-57.
2. Peden VH, Witzleben CL, Skelton MA. TPN. J Pediatr. 1971;78:180-181.
3. Allard JP. Other disease associations with non-alcoholic fatty liver disease (NAFLD). Baillieres Clin Gastroenterol. 2002;16:783-795.
4. Erlinger S. Les consequences hepatiques et biliares de l'alimentation parenterale. Gastroenterol Clin Biol. 1982;6:671-672.
5. Baker A, Rosenberg IH. Hepatic complications of TPN. Am J Med. 1987;82:489-497.
6. Bowyer BA, Fleming CR, Ludwig J, Petz J, McGill DB. Does long-term parenteral nutrition in adult patients cause chronic liver disease? JPEN. 1985;9:11-17.
7. Beale EF, Nelson RM, Bucciarelli RL, Donnely WH, Eitzman DV. Intrahepatic cholestasis associated with parenteral nutrition in premature infants. Pediatrics. 1979;64:342-347.
8. Merritt RJ. Cholestasis associated with TPN. J Pediatr Gastro. enterol Nutr. 1986;5:9-22.
9. Sax HC, Bower RH. Hepatic complications of TPN. JPEN. 1988;12:615-618.
10. Buchman A. Total Parenteral nutrition-associated liver disease. JPEN. 2002;26:S43-S48.
11. Drongowski RA, Coran AG. An analysis of the factors contributing to the development of TPN-induced cholestasis. JPEN. 1989;13:586-589.
12. Alverdy J, Chi HS, Sheldon GF. The effect of parenteral nutrition on gastrointestinal immunity: The importance of enteral stimulation. Ann Surg. 1985;202:681-684.
13. Postuma R, Trevenen CL. Liver disease in infants receiving TPN. Pediatrics. 1979;63:110-115.
14. Sondheimer JM, Asturias E, Cadnapaphornchai M. Infection and cholestasis in neonates with intestinal resection and long-term parenteral nutrition. J Pediatr Gastroenterol Nutr. 1998;27:131-137.
15. Messing B, Bories C, Kunstlinger F, Bernier JJ. Does TPN induce gallbladder sludge formation and lithiasis? Gastroenterology. 1983;84:1012-1019.
16. Pitt HA, King W 3rd, Mann LL, et al. Increased risk of cholelithiasis with prolonged TPN. Am J Surg. 1983;145:106-112.
17. Roslyn JJ, Pitt HA, Mann LL, Ament ME, DenBesten L. Gallbladder disease in patients on long-term parenteral nutrition. Gastroenterology. 1983;84:148-154.
18. Kelly DA. Liver complications of pediatric parenteral nutrition epidemiology. Nutrition. 1998;14:153-157.
19. Cavicchi M, Crenn P, Beau P, Degott C, Boutron MC, Messing B. Severe liver complications associated with long-term parenteral nutrition are dependent on lipid parenteral input. Transplant Proc. 1998;30:2547.
20. Chan S, McCowen KC, Bistrian BR. Incidence, prognosis, and etiology of end-stage liver disease in patients receiving home parenteral nutrition. Surgery. 1999;126:28-34.
21. Luman W, Shaffer JL. Prevalence, outcome and associated factors of deranged liver function test in patients on home parenteral nutrition. Clin Nutr. 2002;21:337-343.
22. Grant JP, Cox CE, Kleinman LM, et al. Serum hepatic enzyme and bilirubin elevations during parenteral nutrition. Surg Gynecol Obstet. 1977;145:573-580.
23. MacFadyen BV Jr, Dudrick SJ, Baquero G, Gum ET. Clinical and biological changes in liver function during intravenous hyperalimentation. JPEN. 1979;3:438-443.
24. Sheldon GF, Peterson SR, Sanders R. Hepatic dysfunction during hyperalimentation. Arch Surg. 1978;113:504-508.
25. Abad-Lacruz A, Gonzalez-Huix F, Esteve M, et al. Liver function tests abnormalities in patients with inflammatory bowel disease receiving artificial nutrition: A prospective randomized study of total enteral nutrition vs TPN. JPEN. 1990;14:618-621.
26. Nanji AA, Anderson FH. Cholestasis associated with parenteral nutrition develops more commonly with hematologic malignancy than with inflammatory bowel disease [letter]. JPEN. 1984;8:325.
27. Wagman LD, Burt ME, Brennan MF. The impact of TPN on liver function tests in patients with cancer. Cancer. 1982;49:1249-1257.
28. Sandhu IS, Jarvis C, Everson GT. Total parenteral nutrition and cholestasis. Clin Liver Dis. 1999;3:489-508.
29. Kubota A, Okada A, Nezu R, Kamata S, Imura K, Takagi Y. Hyperbilirubinemia in neonates with TPN. JPEN. 1988;12:602-606.
30. Nanji AA, Anderson FH. Sensitivity and specificity of liver function tests in the detection of parenteral nutrition associated cholestasis. JPEN. 1985;9:307-308.
31. Lindor KD, Fleming CR, Abrams A, Hirschkorn MA. Liver function values in adults receiving TPN. JAMA. 1979;241:2398-2400.
32. Leaseburge LA, Winn NJ, Schloerb PR. Liver test alterations with TPN and nutritional status. JPEN. 1992;16:348-352.
33. Stanko RT, Nathan G, Mendelow H, Adibi SA. Development of hepatic cholestasis and fibrosis in patients with massive loss of intestine supported by prolonged parenteral nutrition. Gastroenterology. 1987;92:197-202.
34. Quigley EM, Marsh MN, Shaffer JL, Markin RS. Hepatobiliary Complications of TPN. Gastroenterology. 1993;104:286-301.
35. Clarke PJ, Ball MJ, Kettlewell MG. Liver function tests in patients receiving parenteral nutrition. JPEN. 1991;15:54-59.
36. Messing B, Colombel JF, Heresbach D, Chazouilleres O, Galian A. Chronic cholestasis is related to macronutrient excess in patients treated with prolonged parenteral nutrition. Nutrition. 1992;8:30-36.
37. Ito Y, Shils ME. Liver dysfunction associated with long-term TPN in patients with massive bowel resection. JPEN. 1991;15:271-276.
38. Cavicchi M, Beau P, Crenn P, Degott C, Messing B. Prevalence of liver disease and contributing factors in patients receiving home parenteral nutrition for permanent intestinal failure. Ann Intern Med. 2000;132:525-532.
39. Grant D. Intestinal transplantation: 1997 report of the international Registry: Intestinal Transplant Registry. Transplantation. 1999;67:1061-1064.
40. Brousse N, Goulet O. Small bowel transplantation [editorial]. BMJ. 1996;312:261-262.
41. Quigley EM. Small intestinal transplantation: Reflections on an evolving approach to intestinal failure. Gastroenterology. 1996;110:2009-2012.
42. Messing B, Zarka Y, Lemann M, Iglicki F, Coffin B, Rambaud J. Chronic cholestasis associated with long-term parenteral nutrition [abstract]. Transplant Proc. 1994;26:1438-1439.
43. Afdhal N, Smith BF. Current concepts on the pathogenesis of cholesterol gallstones. Viewpoints Dig Dis. 1990;22:13-18.
44. Brown MR, Thunberg BJ, Golub L, Maniscalco WM, Cox C, Shapiro DL. Decreased cholestasis with enteral instead of intravenous protein in the very low-birth-weight infant. J Pediatr Gastroenterol Nutr. 1989;9:21-27.
45. Gleghorn EE, Merritt RJ, Henton DH, Neustein HM, Landing B, Sinatra FR. A subacute rabbit model for hepatobiliary dysfunction during TPN. J Pediatr Gastroenterol Nutr. 1989;9:246-255.
46. Whitington PF. Cholestasis associated with TPN in infants. Hepatology. 1985;5:693-696.
47. Masumoto K, Suita S, Taguchi T, et al. Manganese intoxication during intermittent parenteral nutrition: Report of two cases. JPEN. 2001;25:95-99.
48. Larsen NA, Pakkenberg H, Damsgaard E, Heydorn K. Topographical distribution of arsenic, manganese, and selenium in the normal human brain: J Neurol Sci. 1979;42:458-468.
49. Barrow L, Patel HR, Tanner MS. Alpha-tocopherol deficiency fails to aggravate toxic liver injury but liver injury causes alpha tocopherol retention. J Hepatol. 1992;16:332-337.
50. Burk RF, Early DS, Hill KE. Plasma selenium in patients with Cirrhosis. Hepatology. 1988;27:794-798.
51. Forrest EH, Oien KA, Dickson S, Galloway D, Mills PR. Improvement in cholestasis associated with TPN after treatment with an antibody against tumour necrosis factor alpha. Liver. 2002;22:317-320.
52. Hwang T, Lue M, Chen L. Early use of cyclic TPN prevents further deterioration of liver functions for TPN patients with impaired liver function. Hepatogastroenterology. 2000;47:1347-1350.
53. Doty JE, Pitt HA, Porter-Fink V, DenBesten L. The effect of intravenous fat and TPN on biliary physiology. JPEN. 1984;8:263-268.
54. Carey MC, Cahalane MJ. Whither biliary sludge? Gastroenterology. 1988;95:508-523.
55. Innis SM. Effect of cholecystokinin-octapeptide on TPN-induced changes in hepatic bile secretion and composition in the rat. J Pediatr Gastroenterol Nutr. 1986;5:793-798.
56. Sitzmann JV, Pitt HA, Steinborn PA, Pasha ZR, Sanders RC. Cholecystokinin prevents parenteral nutrition induced biliary sludge in humans. Surg Gynecol Obstet. 1990;170:25-31.
57. Souba WW, Klimberg VS, Plumley DA, et al. The role of glutamine in maintaining a healthy gut and supporting the metabolic response to injury and infection. J Surg Res. 1990;48:383-391.
58. Cano N, Messing B. Consequences hepatiques et biliaires de la nutrition artificielle. Nutr Clin Metab. 1994;8:149-162.
59. Guertin F, Roy CC, Lepage G, et al. Effect of taurine on TPN associated cholestasis. JPEN. 1991;15:247-251.
60. Fouin-Fortunet H, Le Quernec L, Erlinger S, Lerebourse, Colin R. Hepatic alterations during TPN in patients with inflammatory bowel disease: A possible consequence of lithocholate toxicity. Gastroenterology. 1982;82:932-937.
61. Riordan SM, McIver CJ, Williams R. Liver damage in human small intestinal bacterial overgrowth. Am J Gastroenterol. 1998;93:234-237.
62. Chung C, Buchman AL. Postoperative jaundice and TPN-associated hepatic dysfunction. Clin Liver Dis. 2002;6:1067-1084.
63. Meguid MM, Chen TY, Yank ZJ Campos AC, Hitch DC, Gleason JR. Effects of continuous graded TPN on feeding indexes and metabolic concomitants in rats. Am J Physiol. 1990;260:E126-E140.
64. Tulikoura I, Huikuri K. Morphological fatty changes and function of the liver, serum free fatty acids and triglycerides during parenteral nutrition. Scand J Gastroenterol. 1982;17:177-185.
65. Fong DG, Nehra V, Lindor KD, Buchman AL. Metabolic and nutritional considerations in nonalcoholic fatty liver. Hepatology. 2000;32:3-10.
66. Li S, Nussbaum MS, Teague D, Gapen CL, Dayal R, Fischer JE. Increasing dextrose concentrations in total parenteral nutrition (TPN) causes alterations in hepatic morphology and plasma levels of insulin and glucagon in rats. J Surg Res. 1988;44:639-648.
67. Bhatia J, Rassin DK. Photosensitized oxidation of tryptophan and hepatic dysfunction in neonatal gerbils. JPEN. 1985;9:491-495.
68. Kalfarentzos F, Vagenas C, Michail A, et al. Gallbladder contraction after administration of intravenous amino acids and long-chain triacylglycerols in humans. Nutrition. 1991;7:347-349.
69. Merritt RJ, Sinatra FR, Henton D, Neustein H. Cholestatic effect of intraperitoneal administration of tryptophan to suckling rat pups. Pediatr Res. 1984;18:904-907.
70. Vileisis RA, Inwood RJ, Hunt CE. Prospective controlled study of parenteral nutrition-associated cholestatic jaundice: effect of protein intake. J Pediatr. 1980;96:893-897.
71. Moss RL, Das JB, Raffensperger JG. TPN associated cholestasis: Clinical and histopatologic correlation. J Pediatr Surg. 1993;20:604-606.
72. Mason TM. The role of factors that regulate the synthesis and secretion of very-low density lipoprotein by hepatocytes. Crit Rev Clin Lab Sci. 1998;35:461-487.
73. Kaminski DL, Adams A, Jellinek M. The effect of hyperalimentation-hepatic lipid content and lipogenic enzyme activity in rats and man. Surgery. 1980;88:93-100.
74. Clayton PT, Bowron A, Mills KA, Massoud A, Casteels M, Milla PJ. Phytosterolemia in children with parenteral nutrition-associated cholestatic liver disease. Gastroenterology. 1993;105:1806-1813.
75. Cook GC, Hutt MSR. The liver after kwashiorkor. BMJ. 1967;3:454-457.
76. Chang G, Silvis SE. Fatty liver produced by hyperalimentation in rats. Am J Gastroenterol. 1974;62:410-418.
77. Goodgame JT, Lowry SF, Brennan MF. Body weight changes and nutritional adequacy in the parenterally alimented rat. J Surg Res. 1978;4:520-526.
78. Belli DC, Roy CC, Fournier LA, Tuchweber B, Giguere R, Yousef IM. The effect of taurine on cholestatic potential of sulfated lithocholate and its conjugates. Liver. 1991;11:162-169.
79. Rigo J, Senterre J. Is taurine essential for the neonates? Biol Neonate. 1977;32:73-76.
80. Barr LH, Dunn GD, Brennan MF. Essential fatty acid deficiency during TPN. Ann Surgery. 1981;193:304-311.
81. McDonald ATJ, Philips MJ, Jeejeebhoy KN. Reversal of fatty liver by intralipid in patient on total parenteral alimentation [Abstract]. Gastroenterology. 1973;64:885.
82. Reif S, Tano M, Oliverio R, Young C, Rossi T. TPN-induced steatosis: Reversal by parenteral lipid infusion. JPEN. 1991;15:102-104.
83. Buchman AL, Dubin M, Jenden D, et al. Lecithin increases plasma free choline and decreases hepatic steatosis in long-term total parenteral nutrition patients. Gastroenterology. 1992;102:1363-1370.
84. Buchman AL, Dubin MD, Moukarzel AA, et al. Choline deficiency: A cause of hepatic steatosis during parenteral nutrition that can be reversed with intravenous choline supplementation. Hepatology. 1995;22:1399-1403.
85. Lombardi B, Pani P, Schlunk FF. Choline-deficiency fatty liver: Impaired release of hepatic triglycerides. J Lipid Res. 1968;9:437-446.
86. Yao ZM, Vance DE. Reduction in VLDL, but not HDL, in plasma of rats deficient in choline. Biochem Cell Biol. 1990;68:552-558.
87. Buchman AL, Moukarzel A, Jenden DJ, et al. Low plasma free choline is prevalent in patients receiving long term parenteral nutrition and is associated with hepatic aminotransferase abnormalities. Clin Nutr. 1993;12:33-37.
88. Steginck LD, Denbesten L. Synthesis of cysteine from methionine in normal adult subjects: Effect of route of alimentation. Science. 1972;178:514-516.
89. Caraceni P, Nardo B, Domenicali M, et al. Ischemia-reperfusion injury in rat fatty liver: Role of nutritional status. Hepatology. 1999;29:1139-1146.
90. Buchman AL, Ament ME, Sohel M, et al. Choline deficiency causes reversible hepatic abnormalities in patients receiving parenteral nutrition: Proof of human choline requirement: A placebo controlled trial. JPEN. 2001;25:260-268.
91. Berner YN, Larchian WA, Lowry SF, Nicroa RR, Brennan MF, Shike M. Low plasma carnitine in patients on prolonged TPN: Association with low lysine. JPEN. 1990;14:255-258.
92. Bowyer BA, Fleming CR, Ilstrup D Nelson J, Reek S, Burnes J. Plasma carnitine levels in patients receiving home parenteral nutrition. Am J Clin Nutr. 1986;43:85-91.
93. Buchman AL. Complications of long-term home TPN: Their identification, prevention and treatment. Dig Dis Sci. 2001;46:1-18.
94. Karpati G, Carpenter S, Engel AG, et al. The syndrome of systemic carnitine deficiency: Clinical, morphologic, biochemical and pathologic features. Neurology. 1975;25:16-24.
95. Baldermann H, Wicklamayr M, Rett K, Banholzer P, Dietze G, Mehnert H. Changes of hepatic morphology during parenteral nutrition with lipid emulsion containing LCT or MCT/LCT quantified by ultrasound scan. JPEN. 1991;15:601-603.
96. Okamoto E, Rassin DK, Zucker CL, Salen GS, Heird WC. Role of taurine in feeding the low-birth-weight infant. J Pediatr. 1984;104:936-940.
97. Desai TK, Reddy J, Kinzie JL, et al. Taurine supplementation and cholestasis during bone marrow transplantation. Gastroenterology. 1993;104:A616.
98. Teitelbaum DH. Parenteral nutrition-associated cholestasis. Curr Opin Pediatr. 1997;9:270-275.
99. Heathcote EJ, Cauch-Dudek K, Walker V, et al. The Canadian Multicenter Double-blind Randomized Controlled Trial of ursodeoxycholic acid in primary biliary cirrhosis. Hepatology. 1994;19:1149-1156.
100. Cohen IT, Meunier KM, Hirsh MP. The effects of enteral stimulation on gallbladder bile during TPN in the neonatal piglet. J Pediatr Surg. 1990;25:163-167.
101. Doty JE, Pitt HA, Porter-Fink V, Denbesten L. Cholecystokinin prophylaxis of parenteral nutrition-induced gallbladder disease. Ann Surg. 1985;201:76-80.
102. Teitelbaum DH, Han-Markey TH, Drongowski RA, et al. Use of cholecystokinin to prevent the development of parenteral nutrition-associated cholestasis. JPEN. 1997;21:100-103.
103. Capron J-P, Gineston J-L, Herve M-A, Braillon A. Metronidazole in prevention of cholestasis associated with TPN. Lancet. 1983;1:446-447.
104. Spurr SG, Grulack LJ, Mehta NR. Hyperalimentation associated neonatal cholestasis: Effect of oral gentamicin. JPEN. 1989;13:633-636.
105. Grant JP, Snyder PJ. Use of L-glutamine in TPN. J Surg Res. 1988;44:506-513.
106. Li YS, Li JS, Jiang JW, et al. Glycyl-glutamine-enriched TPN attenuates bacterial translocation following small bowel transplantation in the pig. J Surg Res. 1999;82:106-111.
107. Grant JP, Snyder PJ. Effect of glutamine on total fat content of the liver [abstract]. JPEN. 1990;14:8S.
108. Li S, Nussbaum MS, McFaddon DW, et al. Addition of L-glutamine to TPN and its effects on portal insulin and glucagon and development of hepatic steatosis in the rat. J Surg Res. 1990;48:421-426.
109. Yeh SL, Chen WJ, Huang PC. Effect of L-glutamine on hepatic lipids at different energy levels in rats receiving TPN. JPEN. 1994;18:40-44.
110. Hornsby-Lewis L, Shike M, Brown P, Klang M, Pearlstone D, Brennan MF. L-Glutamine supplementation in home TPN patients: stability, safety, and effects on intestinal absorption. JPEN. 1994;18:268-273.
111. Bowyer BA, Fleming CR, Heymond MW, Miles JM. L-Carnitine: Effect of intravenous administration on fuel homeostasis in normal subjects and home-parenteral-nutrition patients with low plasma carnitine concentrations. Am J Clin Nutr. 1989;49:618-623.
112. Ahern DA, Mitchell ME. Liver function in protein-energy malnutrition measured by cinnamic acid tolerance and benzoic acid tolerance: Effects of carnitine supplementation. Br J Nutr. 1989;61:209-221.
113. Sudan DL, Kaufman SS, Shaw BW, et al. Isolated intestinal transplantation for intestinal failure. Am J Gastroenterol. 2000;95:1506-1515.